Evidence map›Paper›PMID 30208029›Full record

ArticlePloS one2018

Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality.

Arturo Orlacchio, Aaron E Stark, Claudia Foray, Foued Amari, Tyler Sheetz, Erika Reese, Anna Tessari, Krista La Perle, Dario Palmieri, Philip N Tsichlis and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Genetic alterations in SUPT6H are associated with neurodevelopmental disorders.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Arturo OrlacchioDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Aaron E StarkArthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Claudia ForayDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Foued AmariArthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Tyler SheetzDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Erika ReeseDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Anna TessariDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Krista La PerleArthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Dario PalmieriDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Philip N TsichlisMolecular Oncology Research Institute, Tufts Medical School, Boston, MA, United States of America.
Vincenzo CoppolaDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0001-6163-1779
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USMolecular Oncology (United States) · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The role of IWS1 in development and tumorigenesisR01CA198117 · NCI · TUFTS MEDICAL CENTER · PI COPPOLA, VINCENZO, TSICHLIS, PHILIP N. · 2015 to 2019
$2.9M
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA198117
6 · The paper itself

Abstract

IWS1 is an RNA-polymerase II (RNAPII)-associated transcription elongation factor whose biological functions are poorly characterized. To shed some light on the function of this protein at the organismal level, we performed a systematic tissue analysis of its expression and generated Iws1-deficient mice. A thorough immunohistochemical characterization shows that IWS1 protein is present in the nucleus of all cells in most of the examined tissues, with few notable exceptions. We also report that ablation of Iws1 consistently causes lethality at the pre-implantation stage with high expression of the gene in fertilized oocytes. In summary, we are providing evidence that Iws1 is expressed in all adult organs and it is an essential gene for mouse embryonic development.

Indexed as

Embryo LossEmbryo, MammalianGene Expression Regulation, DevelopmentalAnimalsMiceOrgan SpecificityTranscription FactorsSupt6 protein, mouseTranscription Factors

Identifiers

PMID30208029
PMCPMC6135376
OpenAlexW2890048182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.